Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives

Number of heterocyclic compounds has been exploited to develop pharmaceutically important molecules, out of which biheterocyclic coumarins are clinically used potential drug candidates showing oral hypoglycemic and antidiabetic activities. A new series of 3-[5'-methyl-2'-aryl-3'-(thia...

Full description

Saved in:
Bibliographic Details
Main Authors: Deepthi Kini, Manjunath Ghate
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:E-Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2011/258680
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551113127100416
author Deepthi Kini
Manjunath Ghate
author_facet Deepthi Kini
Manjunath Ghate
author_sort Deepthi Kini
collection DOAJ
description Number of heterocyclic compounds has been exploited to develop pharmaceutically important molecules, out of which biheterocyclic coumarins are clinically used potential drug candidates showing oral hypoglycemic and antidiabetic activities. A new series of 3-[5'-methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino)thiazolidin-4'-one]coumarin derivatives were designed and synthesized. The title compounds were synthesized from starting material 3- acetyl coumarin. All the synthesized compounds were characterized and screened for hypoglycemic activity. Some of the compounds exhibited promising activity.
format Article
id doaj-art-5beac5ec678e42a2b960eea735ff95f1
institution Kabale University
issn 0973-4945
2090-9810
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series E-Journal of Chemistry
spelling doaj-art-5beac5ec678e42a2b960eea735ff95f12025-02-03T06:04:57ZengWileyE-Journal of Chemistry0973-49452090-98102011-01-018138639010.1155/2011/258680Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin DerivativesDeepthi Kini0Manjunath Ghate1Department of Pharmaceutical Chemistry, Karnataka College of Pharmacy, Bangalore, IndiaDepartment of Pharmaceutical Chemistry, Institute of Pharmacy Nirma University, Ahmedabad-382 481, IndiaNumber of heterocyclic compounds has been exploited to develop pharmaceutically important molecules, out of which biheterocyclic coumarins are clinically used potential drug candidates showing oral hypoglycemic and antidiabetic activities. A new series of 3-[5'-methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino)thiazolidin-4'-one]coumarin derivatives were designed and synthesized. The title compounds were synthesized from starting material 3- acetyl coumarin. All the synthesized compounds were characterized and screened for hypoglycemic activity. Some of the compounds exhibited promising activity.http://dx.doi.org/10.1155/2011/258680
spellingShingle Deepthi Kini
Manjunath Ghate
Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
E-Journal of Chemistry
title Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
title_full Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
title_fullStr Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
title_full_unstemmed Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
title_short Synthesis and Oral Hypoglycemic Activity of 3-[5'-Methyl-2'-aryl-3'-(thiazol-2ʺ-yl amino) thiazolidin-4'-one]coumarin Derivatives
title_sort synthesis and oral hypoglycemic activity of 3 5 methyl 2 aryl 3 thiazol 2 yl amino thiazolidin 4 one coumarin derivatives
url http://dx.doi.org/10.1155/2011/258680
work_keys_str_mv AT deepthikini synthesisandoralhypoglycemicactivityof35methyl2aryl3thiazol2ʺylaminothiazolidin4onecoumarinderivatives
AT manjunathghate synthesisandoralhypoglycemicactivityof35methyl2aryl3thiazol2ʺylaminothiazolidin4onecoumarinderivatives